Gemmer Asset Management’s Epizyme, Inc EPZM Stock Holding History

Gemmer Asset Management’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5	Closed	–	–	1456
2019 Q3	$0	Buy	+5	New	+$63	﹤0.01%	1499

Other funds holding EPZM

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Gemmer Asset Management's EPZM Position: Q4 2019 in Review

Gemmer Asset Management sold out of Epizyme, Inc (EPZM) in Q4 2019, closing a stake of 5 shares.

Gemmer Asset Management first reported a position in EPZM in Q3 2019 and held it in 1 quarter. The position peaked at $0 in Q3 2019. 136 funds tracked by Wall St. Rank hold EPZM as of Q4 2019.

Gemmer Asset Management reported no remaining Epizyme, Inc position as of Q4 2019 after selling out during the quarter.
Gemmer Asset Management sold 5 Epizyme, Inc shares in Q4 2019.
Gemmer Asset Management first reported a position in Epizyme, Inc in Q3 2019 and held it in 1 quarter.
Gemmer Asset Management's Epizyme, Inc position peaked at $0 in Q3 2019.
136 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2019.

Based on Gemmer Asset Management's 13F filing for Q4 2019, filed 17 Jan 2020.